Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Novo Nordisk
Health Tech
Hims & Hers swings to a loss in Q1 amid shift in GLP-1 strategy
Hims & Hers posted a $92 million loss in the first quarter as it transitions its weight loss business away from compounded weight loss drugs.
Heather Landi
May 12, 2026 4:00pm
Amazon Pharmacy to offer home delivery for Novo's Ozempic pill
May 7, 2026 3:42pm
Him & Hers now offers all FDA-approved GLP-1s
Apr 23, 2026 10:43am
GoodRx launches Wegovy HD for $399 per month
Apr 15, 2026 1:38pm
Novo Nordisk rolls out discounted subscription plan for Wegovy
Apr 2, 2026 4:30pm
Hims & Hers makes deal with Novo in obesity strategy shift
Mar 9, 2026 10:53am
